These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35694676)

  • 1. Glycosylation of HDL-Associated Proteins and Its Implications in Cardiovascular Disease Diagnosis, Metabolism and Function.
    Romo EZ; Zivkovic AM
    Front Cardiovasc Med; 2022; 9():928566. PubMed ID: 35694676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins.
    Remaley AT; Wong AW; Schumacher UK; Meng MS; Brewer HB; Hoeg JM
    J Biol Chem; 1993 Mar; 268(9):6785-90. PubMed ID: 8454651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma.
    Kailemia MJ; Wei W; Nguyen K; Beals E; Sawrey-Kubicek L; Rhodes C; Zhu C; Sacchi R; Zivkovic AM; Lebrilla CB
    J Proteome Res; 2018 Feb; 17(2):834-845. PubMed ID: 29212317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis.
    Valanti EK; Dalakoura-Karagkouni K; Sanoudou D
    J Pers Med; 2018 Oct; 8(4):. PubMed ID: 30282955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.
    Savinova OV; Fillaus K; Jing L; Harris WS; Shearer GC
    PLoS One; 2014; 9(8):e104833. PubMed ID: 25118169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.
    Corsetti JP; Bakker SJ; Sparks CE; Dullaart RP
    PLoS One; 2012; 7(6):e39110. PubMed ID: 22723940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease.
    Rye KA
    Clin Exp Nephrol; 2014 Apr; 18(2):247-50. PubMed ID: 24052156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol.
    Savinova OV; Fillaus K; Harris WS; Shearer GC
    Atherosclerosis; 2015 Jun; 240(2):520-5. PubMed ID: 25932792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
    Rotllan N; Price N; Pati P; Goedeke L; Fernández-Hernando C
    Atherosclerosis; 2016 Mar; 246():352-60. PubMed ID: 26828754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease.
    Liao D; Yang X; Wang H
    Clin Chem Lab Med; 2007; 45(12):1652-9. PubMed ID: 18020970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.
    Mora S; Glynn RJ; Ridker PM
    Circulation; 2013 Sep; 128(11):1189-97. PubMed ID: 24002795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
    Millwood IY; Bennett DA; Holmes MV; Boxall R; Guo Y; Bian Z; Yang L; Sansome S; Chen Y; Du H; Yu C; Hacker A; Reilly DF; Tan Y; Hill MR; Chen J; Peto R; Shen H; Collins R; Clarke R; Li L; Walters RG; Chen Z;
    JAMA Cardiol; 2018 Jan; 3(1):34-43. PubMed ID: 29141072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
    van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
    J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary genetic disorders affecting high density lipoprotein (HDL).
    Kosmas CE; Silverio D; Sourlas A; Garcia F; Montan PD; Guzman E
    Drugs Context; 2018; 7():212546. PubMed ID: 30214464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway.
    Lu J; Hübner K; Nanjee MN; Brinton EA; Mazer NA
    PLoS Comput Biol; 2014 Mar; 10(3):e1003509. PubMed ID: 24625468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
    Asztalos BF; Collins D; Cupples LA; Demissie S; Horvath KV; Bloomfield HE; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2185-91. PubMed ID: 16123324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.